Breadcrumb

By the Numbers

Image
  • 393 Open Clinical Trials
  • 29 New Clinical Trials
  • 1,686 New Patients
Image
  • 244 Principal Investigators
  • 9 New Faculty Recruits*
  • 5 Newly Tenured Investigators*
  • 296/87 Staff Scientists/Staff Clinicians
  • ~600 Technical Lab Staff
  • 832/115 Postdoctoral/Clinical Fellows
  • 375/75 Postbaccalaureate/Predoctoral Students
  • 207 Summer Students
Image
  • >1,100 Articles in Peer-Reviewed Journals
Image
  • 64 Technology Facilities and Platforms

Technology Transfer Activities

Image
Green Reports Icon
  • 85 New Employee Invention Reports
  • 27 Issued U.S. Patents
  • 31 New Cooperative Research and Development Agreements (CRADAs)
  • 187 Active CRADAs
  • 92 Clinical CRADAs
  • 7 Umbrella CRADAs
  • 10 New Clinical Trial Agreements (CTAs)
  • 114 Active CTAs
Image
Green Licenses Icon
  • 125 New Licenses for CCR Technologies
  • 675 Active Licenses
Image
  • 1 FDA Approval
  • 1 FDA Orphan Drug Designation*
  • 1 FDA Breakthrough Therapy Designation

The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices and software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.

For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).

Numbers are for fiscal year 2023 unless otherwise marked.
*Numbers are for calendar year 2023.